{
    "root": "12683a0e-eb9e-442e-b650-4e4d387844bf",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Piperacillin and Tazobactam",
    "value": "20241030",
    "ingredients": [
        {
            "name": "PIPERACILLIN SODIUM",
            "code": "M98T69Q7HP"
        },
        {
            "name": "TAZOBACTAM SODIUM",
            "code": "UXA545ABTT"
        }
    ],
    "indications": "piperacillin tazobactam injection combination piperacillin , penicillin-class antibacterial tazobactam , beta-lactamase inhibitor , indicated treatment : • intra-abdominal infections adult pediatric patients 2 months age older ( 1.1 ) • nosocomial pneumonia adult pediatric patients 2 months age older ( 1.2 ) • skin skin structure infections adults ( 1.3 ) • female pelvic infections adults ( 1.4 ) • community-acquired pneumonia adults ( 1.5 ) reduce development drug-resistant bacteria maintain effectiveness piperacillin tazobactam injection antibacterial drugs , piperacillin tazobactam injection used treat prevent infections proven strongly suspected caused bacteria . ( 1.6 )",
    "contraindications": "• adult patients nosocomial pneumonia : usual daily piperacillin tazobactam injection adults 3.375 g every six hours totaling 13.5 g ( 12 g piperacillin 1.5 g tazobactam ) . ( 2.1 ) • adult patients nosocomial pneumonia : initial presumptive treatment patients nosocomial pneumonia start piperacillin tazobactam injection 4.5 g every six hours plus aminoglycoside , totaling 18 g ( 16 g piperacillin 2 g tazobactam ) . ( 2.2 ) • adult patients renal impairment : patients renal impairment ( creatinine clearance ≤ 40 ml/min ) dialysis patients reduced , based degree renal impairment . ( 2.3 ) • pediatric patients indication age : table . ( 2.4 ) recommended piperacillin tazobactam injection pediatric patients 2 months age older , weighing 40 kg normal renal function age appendicitis /or peritonitis nosocomial pneumonia 2 months 9 months 90 mg/kg ( 80 mg piperacillin 10 mg tazobactam ) every 8 ( eight ) hours 90 mg/kg ( 80 mg piperacillin 10 mg tazobactam ) every 6 ( six ) hours older 9 months 112.5 mg/kg ( 100 mg piperacillin 12.5 mg tazobactam ) every 8 ( eight ) hours 112.5 mg/kg ( 100 mg piperacillin 12.5 mg tazobactam ) every 6 ( six ) hours • administer piperacillin tazobactam injection intravenous infusion 30 minutes adult pediatric patients . ( 2.1 , 2.2 , 2.3 , 2.4 ) • piperacillin tazobactam injection aminoglycosides reconstituted , diluted , administered separately . co-administration via y-site done certain conditions . ( 2.6 ) • full prescribing information preparation instructions piperacillin tazobactam injection single-dose vials .",
    "warningsAndPrecautions": "piperacillin tazobactam injection , usp supplied single-dose vials following sizes : piperacillin tazobactam injection , usp 2.25 g vial provides piperacillin sodium equivalent 2 grams piperacillin tazobactam sodium equivalent 0.25 g tazobactam . vial contains 4.69 meq ( 108 mg ) sodium . supplied 10 per box – ndc 0781-9210-95 piperacillin tazobactam injection , usp 3.375 g single-dose vial provides piperacillin sodium equivalent 3 grams piperacillin tazobactam sodium equivalent 0.375 g tazobactam . vial contains 7.04 meq ( 162 mg ) sodium . supplied 10 per box – ndc 0781-9213-95 piperacillin tazobactam injection , usp 4.5 g single-dose vial provides piperacillin sodium equivalent 4 grams piperacillin tazobactam sodium equivalent 0.5 g tazobactam . vial contains 9.39 meq ( 216 mg ) sodium . supplied 10 per box – ndc 0781-9214-95 piperacillin tazobactam injection , usp vials stored 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] prior reconstitution .",
    "adverseReactions": "piperacillin tazobactam injection contraindicated patients history allergic penicillins , cephalosporins , beta-lactamase inhibitors .",
    "indications_original": "Piperacillin and tazobactam for injection is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: • Intra-abdominal infections in adult and pediatric patients 2 months of age and older ( 1.1 ) • Nosocomial pneumonia in adult and pediatric patients 2 months of age and older ( 1.2 ) • Skin and skin structure infections in adults ( 1.3 ) • Female pelvic infections in adults ( 1.4 ) • Community-acquired pneumonia in adults ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of piperacillin and tazobactam for injection and other antibacterial drugs, piperacillin and tazobactam for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.6 )",
    "contraindications_original": "• Adult Patients with Indications Other Than Nosocomial Pneumonia: The usual daily dosage of piperacillin and tazobactam for injection for adults is 3.375 g every six hours totaling 13.5 g (12 g piperacillin and 1.5 g tazobactam). ( 2.1 ) • Adult Patients with Nosocomial Pneumonia: Initial presumptive treatment of patients with nosocomial pneumonia should start with piperacillin and tazobactam for injection at a dosage of 4.5 g every six hours plus an aminoglycoside, totaling 18 g (16 g piperacillin and 2 g tazobactam). ( 2.2 ) • Adult Patients with Renal Impairment: Dosage in patients with renal impairment (creatinine clearance ≤ 40 mL/min) and dialysis patients should be reduced, based on the degree of renal impairment. ( 2.3 ) • Pediatric Patients by Indication and Age: See Table below. ( 2.4 ) Recommended Dosage of Piperacillin and Tazobactam for Injection for Pediatric Patients 2 months of Age and Older, Weighing up to 40 kg and With Normal Renal Function Age Appendicitis and /or Peritonitis Nosocomial Pneumonia 2 months to 9 months 90 mg/kg (80 mg piperacillin and 10 mg tazobactam) every 8 ( eight ) hours 90 mg/kg (80 mg piperacillin and 10 mg tazobactam) every 6 ( six ) hours Older than 9 months 112.5 mg/kg (100 mg piperacillin and 12.5 mg tazobactam) every 8 ( eight ) hours 112.5 mg/kg (100 mg piperacillin and 12.5 mg tazobactam) every 6 ( six ) hours • Administer piperacillin and tazobactam for injection by intravenous infusion over 30 minutes to both adult and pediatric patients. ( 2.1 , 2.2 , 2.3 , 2.4 ) • Piperacillin and tazobactam for injection and aminoglycosides should be reconstituted, diluted, and administered separately. Co-administration via Y-site can be done under certain conditions. ( 2.6 ) • See the full prescribing information for the preparation and administration instructions for piperacillin and tazobactam for injection single-dose vials.",
    "warningsAndPrecautions_original": "Piperacillin and tazobactam for injection, USP is supplied as single-dose vials in the following sizes:\n                  Each piperacillin and tazobactam for injection, USP 2.25 g vial provides piperacillin sodium equivalent to 2 grams of piperacillin and tazobactam sodium equivalent to 0.25 g of tazobactam. Each vial contains 4.69 mEq (108 mg) of sodium.\n                  Supplied 10 per box – NDC 0781-9210-95\n                  Each piperacillin and tazobactam for injection, USP 3.375 g single-dose vial provides piperacillin sodium equivalent to 3 grams of piperacillin and tazobactam sodium equivalent to 0.375 g of tazobactam. Each vial contains 7.04 mEq (162 mg) of sodium.\n                  Supplied 10 per box – NDC 0781-9213-95\n                  Each piperacillin and tazobactam for injection, USP 4.5 g single-dose vial provides piperacillin sodium equivalent to 4 grams of piperacillin and tazobactam sodium equivalent to 0.5 g of tazobactam. Each vial contains 9.39 mEq (216 mg) of sodium.\n                  Supplied 10 per box – NDC 0781-9214-95\n                  Piperacillin and tazobactam for injection, USP vials should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] prior to reconstitution.",
    "adverseReactions_original": "Piperacillin and tazobactam for injection is contraindicated in patients with a history of allergic reactions to any of the penicillins, cephalosporins, or beta-lactamase inhibitors."
}